Read Our Latest Issue How the costly race to enroll subjects in psychiatric research trials is harming patients and compromising treatment One evening in the emergency room, I was asked to evaluate a patient requesting admission to the psychiatric unit. Gia was waiting for me, looking pale but fit. (All individuals identified only by their first name have been assigned pseudonyms, and their identifying details have been changed.) She had heard that the hospital was recruiting inpatients for a study of bipolar disorder and wanted to participate. She described herself as moody--upbeat for a few hours, then down, then happy again. This is a preview. Make a selection below to access this issue.Already have access? . Having trouble accessing this article? Please visit our page for more information Discover new insights into neuroscience, human behavior and mental health with Scientific American Mind. Follow us Scientific american arabic (c) 2021 Scientific American, a Division of Springer Nature America, Inc. All Rights Reserved. Support our award-winning coverage of advances in science & technology. Already a subscriber? Subscribers get more award-winning coverage of advances in science & technology.